ZIGExN (3679) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
12 May, 2026Executive summary
FY2026/3 saw record highs in revenue (¥29,221M, +15% YoY), EBITDA (¥7,592M, +7%), operating income (¥5,913M, +5%), and EPS (¥41.66, +9%).
All profit metrics met or exceeded initial plans, driven by strong performance in Vertical HR and successful M&A.
The business is anchored by the Life Service Platform, with core segments in Vertical HR, Living Tech, and Life Service, all showing steady demand despite some geopolitical and inflationary pressures.
The 2nd Medium-Term Management Plan (MTMP) achieved transformation of Vertical HR into Z CORE (over ¥10B revenue), though overall targets were missed.
The 3rd MTMP targets over ¥50B revenue and ¥12B EBITDA by FY2031/3, focusing on deeper workflow integration and AI-driven growth.
Financial highlights
Revenue: ¥29,221M (+15% YoY, 104% of forecast); EBITDA: ¥7,592M (+7% YoY, 102% of forecast); Operating income: ¥5,913M (+5% YoY, 101% of forecast); Net income: ¥4,157M (+7% YoY, 103% of forecast).
EPS: ¥41.66 (+9% YoY, 104% of forecast).
Cash flow from operations: ¥5,427M; investing CF: -¥3,825M; financing CF: -¥2,018M.
Goodwill-to-equity ratio: 0.6x; equity ratio: 55.5%.
ROE maintained at ~20%.
Outlook and guidance
FY2027/3 forecast: revenue ¥33,500M (+15% YoY), EBITDA ¥8,320M (+10%), operating income ¥6,430M (+9%), net income ¥4,390M (+6%), EPS ¥44.09 (+6%).
3rd MTMP targets: revenue >¥50B, EBITDA >¥12B, ROE ~20% by FY2031/3.
Dividend forecast for FY2027/3: ¥13.5/share (payout ratio ~30%).
Latest events from ZIGExN
- Aiming for JPY 50B+ revenue by 2031 through AI-driven matching, M&A, and talent optimization.3679
Investor presentation12 May 2026 - Revenue and net income up YoY, with strong HR growth and higher dividends forecast.3679
Q3 20269 Feb 2026 - Record revenue and profit, 10% growth and higher dividends forecast for FY2026.3679
Q4 202515 Nov 2025 - Q2 revenue up 12.3% YoY, record profits, strong HR, and robust progress toward annual targets.3679
Q2 202611 Nov 2025 - Record Q1 revenue and EBITDA, but net income declined slightly; outlook unchanged.3679
Q1 202612 Aug 2025 - Record Q1 growth and improved margins support unchanged full-year guidance.3679
Q1 202513 Jun 2025 - Double-digit Q2 growth, strong core segments, and higher shareholder returns.3679
Q2 202513 Jun 2025 - Revenue up 10% YoY, outlook revised down, shareholder returns enhanced.3679
Q3 20259 Jun 2025